Show Summary Details
Page of

Hepatitis B-associated renal diseases 

Hepatitis B-associated renal diseases
Hepatitis B-associated renal diseases

Kar Neng Lai

and Sydney C.W. Tang

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 09 August 2020

1. HBV-related glomerulopathy is associated with chronic immune complex formation in situ.

2. The pathologies include MN, mesangiocapillary nephropathy and mesangial proliferative GN with IgA deposits.

3. The development of individual pathology is related to the size of the HBV antigens.

4. The glomerulopathy progresses slowly with development of end-stage renal failure if untreated.

5. Anti-viral agents are effective in slowing the progression of the renal failure. Symptomatic improvement occurs with eradication of the virus

6. Prevention by an effective vaccination programme is far superior to anti-viral treatment despite the fact that new anti-viral therapy is promising on a long-term carrier.

7. A national vaccination for newborn in endemic areas is strongly recommended.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.